1-oleoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine

Metabolite details

Identifier

MWONMGIZXLAUBR-QUBHBNJHSA-N

InChI Key

MWONMGIZXLAUBR-QUBHBNJHSA-N

IUPAC name

O-(hydroxy{(2R)-2-[(9Z,12Z)-octadeca-9,12-dienoyloxy]-3-[(9Z)-octadec-9-enoyloxy]propoxy}phosphoryl)-L-serine

Preferred name

1-oleoyl-2-linoleoyl-sn-glycero-3-phospho-L-serine

INN name

—

Synonym

18:1-18:2-PS

ChEBI

CHEBI:75096

Reactome pathways

• No Reactome pathways listed for this metabolite.

Observed in studies

• Distinct succinate modifying products are clinically diagnostic and prognostic biomarkers for fumarate hydratase deficient renal cell carcinoma
• PatA mediates biofilm formation and drugs resistance through regulating the synthesis of glycolipids and lipids in mycobacterium PatA mediates a novel mycolic acid synthesis pathway and regulates biofilm formation in mycobacterium
• LION-web validation lipidomics experiments (FA-incorporation, membrane fluidty)

Observed in differential profiles

• Normal_control_no_tumor_vs_FH_deficient_RCC
• wild_type_vs_patA_deletion
• BSA_Control_vs_AA